Here's Why Baron Funds Became Bullish in Bio-Techne Corp. (T

Here's Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH)


Here’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH)
Baron Funds, an asset management firm, published its “Baron Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 0.94% was delivered by the fund’s institutional shares for the Q1 of 2021, trailing its primary benchmark, the Russell 2000 Growth Index, that rose to 4.88% and the S&P 500 Index that delivered a 6.17% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Baron Growth Fund, in its Q1 2021 investor letter, mentioned Bio-Techne Corporation (NASDAQ: TECH), and shared their insights on the company. Bio-Techne Corporation is a Minneapolis, Minnesota-based biotechnology company that currently has a $15.9 billion market capitalization. Since the beginning of the year, TECH delivered a 28.76% return, extending its 12-month gains to 56.16%. As of May 12, 2021, the stock closed at $408.88 per share.

Related Keywords

Minnesota , United States , , Federal Reserve , Baron Growth Fund , Bio Techne Corporation , Baron Funds , Growth Fund , Techne Corporation , With Highest Medical Research Spending , Popular Stocks Among Hedge , Insider Monkey , Free Daily Newsletter , மினசோட்டா , ஒன்றுபட்டது மாநிலங்களில் , கூட்டாட்சியின் இருப்பு , பரோன் வளர்ச்சி நிதி , உயிர் தொழில்நுட்பம் நிறுவனம் , பரோன் நிதி , வளர்ச்சி நிதி , தொழில்நுட்பம் நிறுவனம் , உடன் மிக உயர்ந்தது மருத்துவ ஆராய்ச்சி செலவு , பாப்யுலர் ஸ்டாக்ஸ் மத்தியில் ஹெட்ஜ் , உள் குரங்கு , இலவசம் தினசரி செய்திமடல் ,

© 2025 Vimarsana